Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3

NCT04820010 is registered in ClinicalTrials.gov with Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. as lead sponsor.

NCT NCT04820010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04820010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3
Lead sponsor
Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.
Phase
Observational
Overall status
Completed
Start date
October 1, 2018
Completion date
November 1, 2020
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corneal epithelium defect, corneal perforation, corneal ulcer, neurotrophic keratitis